 |
 |
Thursday, July 29, 2010
|
|
|
|
|
|
|
|
|
 |
|
|
|
2008 Medtech Patent Scorecard 5/19/2009 11:57:15 AM Medical device manufacturers value their patent portfolios highly—and with good reason. Within the medical device industry, intellectual property (IP) based on strong research and development (R&D) activity has long played an integral role in driving market success.
Medical device manufacturers value their patent portfolios highly—and with good reason. Within the medical device industry, intellectual property (IP) based on strong research and development (R&D) activity has long played an integral role in driving market success.
For the past 40 years, The Patent Board (Chicago and Philadelphia) has tracked corporate innovation across multiple industries by analyzing patents based on proprietary indicators that measure the impact and relation to research of companies' IP portfolios (see sidebar).
Among the 17 industries tracked by The Patent Board, the medical device industry currently ranks fifth based on the strength of the science behind its collective patent portfolios. It falls just behind the semiconductor, information technology, pharmaceutical, and biotechnology industries. However, out of all of the industries, medtech has the fourth-highest current impact score, far outstripping pharmaceuticals and biotechnology. The industry also nearly doubled the technology strength scores of pharma and biotech. However, medtech's technology strength score of 50 remains average when compared across all industries.
Over the past year, the medtech industry also outpaced pharma and biotech in terms of its technology strength indicator, which is a key measure of overall IP quality and quantity. In this category, the medical device industry more than doubled the score of its pharma and biotech counterparts; across all industries, however, the medtech industry's technology strength remains average.
In this article, MX and The Patent Board again team up to present this year's Medtech Patent Scorecard. The snapshot of the IP landscape presented in this article is based on data that were compiled in February 2008.
Return
|
|
|
|
|
|
|
|
|
|